Navigation Links
Latest Breast Imaging Techniques Offer New Views

Neither will replace mammography for screening yet, experts say,,,,

WEDNESDAY, Dec. 3 (HealthDay News) -- Two newer breast imaging techniques will help doctors diagnose and stage breast cancer, but neither technique will replace standard mammography for the detection of breast cancer.

Both tests -- breast-specific gamma imaging (BSGI) and positron emission mammography (PEM) -- rely on the use of radiotracers to detect cancer cells. The tracer used in BSGI is positively charged, while cancer cells are negatively charged, so the tracer diffuses around the cancer cells and highlights them in the process. The radiotracer used in PEM contains glucose, which is used by cells for energy. Since cancer cells use more energy, they take up more of the tracer and are highlighted on the image.

"I think it's exciting that we're moving more to functional imaging," said Dr. Patrick Borgen, director of the Brooklyn Breast Cancer Program at the Maimonides Cancer Center in Brooklyn, N.Y.

But, he added, "mammography is the mainstay of breast cancer screening, and neither of these tests is in a position to replace mammography as the cornerstone of cancer detection. These tests are adjuncts." Borgen was not involved in either study.

Results from both studies were expected to be presented Wednesday at the Radiological Society of North America's annual meeting, in Chicago. Authors from both studies sit on the boards of the companies that make the new imaging machines.

In one study, 208 women with breast cancer underwent PEM to assess whether or not this imaging technique was affected by the density of breasts or a woman's hormonal status.

The PEM scanner looks similar to a mammogram scanner. It does immobilize the breast, but doesn't compress it, according to study author Dr. Kathy Schilling, director of breast imaging and intervention at the Center for Breast Care at the Boca Raton Community Hospital in Florida.

Cancer was accurately detected in 100 percent of fatty breasts, 93 percent of dense breasts, 85 percent of extremely dense breasts, 93 percent of women regardless of whether or not they had used hormone replacement therapy, 90 percent of pre-menopausal women, and 94 percent of postmenopausal women. Schilling said these results are similar to, or better than, breast MRI tests.

"PEM is an adjunctive tool, and it will probably be used as breast MRI has been used," said Schilling, who added that "MRI causes so many more false positives and unnecessary biopsies."

The second study, which was led by Dr. Rachel Brem from George Washington University Medical Center in Washington, D.C., reviewed data from 159 women who'd been found to have a suspicious lesion after mammography. The women then underwent BSGI scanning, which uses mild compression to capture the images from the tracer.

The researchers found that BSGI located an additional suspicious lesion in 29 percent of the women. Of these, another third were found to be cancerous.

"The data suggest that BSGI allows for the diagnosis of more and earlier breast cancers," Brem said in a statement.

Neither test is widely available yet, and Borgen said that BSGI was much less expensive than PEM to perform right now.

More information

To learn more about mammography and other breast imaging techniques, visit the American Cancer Society.

SOURCES: Patrick Borgen, M.D., director, Brooklyn Breast Cancer Program, Maimonides Cancer Center, Brooklyn, N.Y.; Kathy Schilling, M.D., director, breast imaging and intervention, Center for Breast Care, Boca Raton Community Hospital, Fla.; Dec. 3, 2008, presentations, Radiological Society of North America annual meeting, Chicago

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. VA Sends Latest Gulf War Illness Report to IOM for Review
2. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, X-Ray Tubes, and Cancer Treatment Technologies at RSNA This Year
3. Accent Dual Mode Skin Tightening Laser is Latest Offering from Juva Skin Center
4. Fertility experts present the latest research at reproductive medicine meeting
5. SNM to showcase the latest research in molecular imaging and nuclear medicine
6. Zimmermans Latest Win Has Everyone Smiling
7. Latest Pistachio Study Reveals Significant Reduction in Markers of Inflammation - an Emerging Risk Factor in Heart Disease
8. Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course
9. Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer
10. Latest LOGICARE(R) EDIS User Sees Tremendous Results
11. Latest Trick-or-Treats Give You Something Good to Eat
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology: